Delivery Order SPE2DR25D3021-SPE2DR26FS8LL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections, with a ceiling value of $14,765.85. This is a firm fixed-price delivery order with an ultimate completion date of November 14, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform this contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) valued at $14,661.05. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through open competition. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,833.32 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award is not set-aside and was competitively awarded, reflecting the contractor's...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 22, 2025. This non-competitive delivery order represents a single pharmaceutical procurement from the company's extensive federal contract portfolio. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $7,804.29 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This contract represents a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. As a leading pharmaceutical...
- The Defense Logistics Agency awarded a $9,594.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of October 30, 2025. This non-set-aside competitive award was issued on October 29, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen...
- The Defense Logistics Agency awarded a $42,885.60 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price contract, with an ultimate completion date of August 7, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Forteo 560 micrograms per 2.24 milliliter pen injections, valued at $8,856.07. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $13,007.15 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) under a firm fixed price contract. The award was made on July 10, 2025, with an ultimate completion date of July 11, 2025, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania location. This is a non-set-aside contract awarded through competitive procurement, reflecting the contractor's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $10,392.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 ml pen injections) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- SPE2DR25D3021Indefinite Delivery Contract
- SPE2DR25D3021-SPE2DR26FS8LLDelivery Order
The Defense Logistics Agency awarded a $11,239.10 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This competitive, firm fixed-price delivery order is set to be completed by December 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-line procurement of this specialized pharmaceutical product to support federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to fulfill medical commodity needs across multiple therapeutic domains for defense and federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 12/1/25 |